Page 4 - Nasdaq Caba News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq caba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Caba Today - Breaking & Trending Today

Cabaletta Bio (NASDAQ:CABA) Stock Price Down 4.2%

Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) traded down 4.2% during trading on Monday . The company traded as low as $17.17 and last traded at $17.20. 167,698 shares changed hands during trading, a decline of 70% from the average session volume of 560,050 shares. The stock had previously closed at $17.96. […] ....

United States , Stifel Nicolaus , Gwendolyn Binder , Cabaletta Bio Inc , Victory Capital Management Inc , Wells Fargo Company , Bain Capital Life Sciences Investors , American International Group Inc , Affinity Asset Advisors , Cabaletta Bio , Get Free Report , Capital Management , International Group , Asset Advisors , Capital Life Sciences Investors , Commodore Capital , Cabaletta Bio Daily , Nasdaq Caba ,

Cabaletta Bio (NASDAQ:CABA) Price Target Raised to $50.00

Cabaletta Bio (NASDAQ:CABA – Free Report) had its price target raised by Cantor Fitzgerald from $40.00 to $50.00 in a research report sent to investors on Wednesday, Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the stock. Several other equities research analysts also recently weighed in on CABA. Stifel Nicolaus started coverage on […] ....

Gwendolyn Binder , Stifel Nicolaus , Fred Alger Management , Redmile Group , Cabaletta Bio Inc , Wells Fargo Company , Cantor Fitzgerald , Bain Capital Life Sciences Investors , Cabaletta Bio , Free Report , Alger Management , Asset Management , Capital Life Sciences Investors , Get Free Report , Cabaletta Bio Daily , Nasdaq Caba , Boost Price Target ,

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Rating of "Buy" from Brokerages

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned an average recommendation of “Buy” from the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have issued a report on the stock in the […] ....

Gwendolyn Binder , Stifel Nicolaus , Securities Exchange Commission , Bain Capital Life Sciences Investors , Cabaletta Bio Company Profile , Cabaletta Bio Inc , Blackrock Inc , Wells Fargo Company , Cantor Fitzgerald , Fred Alger Management , Cabaletta Bio , Get Free Report , Marketbeat Ratings , Wells Fargo , Exchange Commission , Alger Management , Asset Management , Capital Life Sciences Investors , Get Free , Cabaletta Bio Daily , Nasdaq Caba ,

Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $21.00

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have updated their coverage on the stock in the […] ....

Gwendolyn Binder , Securities Exchange Commission , Vanguard Group Inc , Cabaletta Bio Inc , York Mellon Corp , Renaissance Technologies , Wells Fargo Company , Acadian Asset Management , Dynamic Technology Lab Private Ltd , Cabaletta Bio , Get Free Report , Exchange Commission , New York Mellon Corp , Asset Management , Technology Lab Private Ltd , Get Free , Cabaletta Bio Daily , Nasdaq Caba ,

Cabaletta Bio (NASDAQ:CABA) Stock Rating Reaffirmed by HC Wainwright

Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $17.00 price objective on the stock. HC Wainwright’s price objective indicates a potential upside of 9.32% from the stock’s current price. A number of […] ....

Gwendolyn Binder , Ameritas Investment Partners Inc , Wells Fargo Company , Envestnet Asset Management Inc , Advisor Group Holdings Inc , Barclays Plc , Cabaletta Bio Inc , Freedom Wealth Alliance , Cabaletta Bio , Get Free Report , Investment Partners , Wealth Alliance , Asset Management , Advisor Group Holdings , Group Holdings , Cabaletta Bio Daily , Nasdaq Caba , Reiterated Rating , Hc Wainwright ,